Brief: S2medical Gets Market Authorization For Epiprotect Series In Malaysia

S2Medical AB (publ)

23/01/2024 11:24

Jan 23 (Reuters) - S2Medical AB (publ)  S2ME.ST :
    * RECEIVES MARKET AUTHORIZATION FOR EPIPROTECT SERIES IN
MALAYSIA
    * THE APPROVAL ISSUED BY THE MEDICAL DEVICE AUTHORITY IS
VALID
UNTIL 2029

Source text for Eikon:  ID:nWkr1SvbS4 
Further company coverage:  S2ME.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))